000952 广济药业
交易中 11-19 14:54:57
资讯
新帖
简况
异动快报:广济药业(000952)11月19日10点14分触及涨停板
证券之星 · 10:15
异动快报:广济药业(000952)11月19日10点14分触及涨停板
广济药业:子公司广化制药拟增资扩股引入投资者
美港电讯 · 11-15
广济药业:子公司广化制药拟增资扩股引入投资者
广济药业最新公告:全资子公司广化制药拟增资扩股引入战略投资者
证券之星 · 11-15
广济药业最新公告:全资子公司广化制药拟增资扩股引入战略投资者
广济药业(000952.SZ)子公司广化制药拟通过公开挂牌引入战略投资者
智通财经 · 11-15
广济药业(000952.SZ)子公司广化制药拟通过公开挂牌引入战略投资者
【企业动态】广济药业新增1件法院诉讼,案由为证券虚假陈述责任纠纷
证券之星 · 11-15
【企业动态】广济药业新增1件法院诉讼,案由为证券虚假陈述责任纠纷
广济药业(000952)11月14日主力资金净买入616.26万元
证券之星 · 11-14
广济药业(000952)11月14日主力资金净买入616.26万元
广济药业(000952)被立案,股民索赔分析
市场资讯 · 11-05
广济药业(000952)被立案,股民索赔分析
广济药业前期会计差错被行政监管,后又因违规信披被立案!
市场资讯 · 11-04
广济药业前期会计差错被行政监管,后又因违规信披被立案!
广济药业(000952)被证监会立案,股民可索赔
市场资讯 · 10-31
广济药业(000952)被证监会立案,股民可索赔
广济药业(000952)9月30日股东户数3.05万户,较上期减少1.98%
证券之星 · 10-30
广济药业(000952)9月30日股东户数3.05万户,较上期减少1.98%
广济药业最新公告:拟公开挂牌转让湖北广济医药科技有限公司90%股权
证券之星 · 10-30
广济药业最新公告:拟公开挂牌转让湖北广济医药科技有限公司90%股权
广济药业:拟公开挂牌转让湖北广济医药科技有限公司90%股权
美港电讯 · 10-30
广济药业:拟公开挂牌转让湖北广济医药科技有限公司90%股权
广济药业(000952)遭证监会立案调查,将面临投资者索赔
市场资讯 · 10-30
广济药业(000952)遭证监会立案调查,将面临投资者索赔
广济药业涉嫌信披违规被立案,投资索赔预登记
市场资讯 · 10-29
广济药业涉嫌信披违规被立案,投资索赔预登记
广济药业(000952)被证监会立案投资者可索赔,鹏欣资源(600490)索赔案持续推进
市场资讯 · 10-29
广济药业(000952)被证监会立案投资者可索赔,鹏欣资源(600490)索赔案持续推进
广济药业(000952)10月28日主力资金净卖出709.53万元
证券之星 · 10-28
广济药业(000952)10月28日主力资金净卖出709.53万元
华闻集团、广济药业、宁波方正遭证监会立案 投资者或可索赔
市场资讯 · 10-28
华闻集团、广济药业、宁波方正遭证监会立案 投资者或可索赔
广济药业、华闻集团股票索赔:涉嫌信披违规被立案,投资者可做索赔准备
市场资讯 · 10-28
广济药业、华闻集团股票索赔:涉嫌信披违规被立案,投资者可做索赔准备
广济药业(000952)被立案,股民索赔可期
市场资讯 · 10-28
广济药业(000952)被立案,股民索赔可期
本周累计10家上市公司公告公司或相关方被立案 公告次日诺泰生物盘中逼近20CM跌停
美港电讯 · 10-27
本周累计10家上市公司公告公司或相关方被立案 公告次日诺泰生物盘中逼近20CM跌停
暂无数据
公司概况
公司名称:
湖北广济药业股份有限公司
所属行业:
医药制造业
上市日期:
1999-11-12
主营业务:
湖北广济药业股份有限公司主要从事维生素 B2、B6原料系列产品以及医药制剂产品的研发、生产和销售等业务。公司主要产品分为原料系列产品、制剂系列产品,其中:原料系列产品为医药级、食品级、98%饲料级、80%饲料级核黄素及核黄素磷酸钠;制剂系列产品为口服固体制剂和大输液。公司是国内较早从事维生素生产的企业之一,经过50多年的研发、生产与经营,现已成为国内生产规模领先、市场地位突出的生产企业,具有明显的规模优势。
发行价格:
5.03
{"stockData":{"symbol":"000952","market":"SZ","secType":"STK","nameCN":"广济药业","latestPrice":6.41,"timestamp":1731999297000,"preClose":5.83,"halted":0,"volume":21269530,"delay":0,"floatShares":344000000,"shares":350000000,"eps":-0.6627,"marketStatus":"交易中","marketStatusCode":2,"change":0.58,"latestTime":"11-19 14:54:57","open":5.86,"high":6.41,"low":5.86,"amount":134000000,"amplitude":0.0943,"askPrice":0,"askSize":0,"bidPrice":6.41,"bidSize":60689,"shortable":0,"etf":0,"ttmEps":-0.6627,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1731999600000},"adr":0,"adjPreClose":5.83,"symbolType":"stock","openAndCloseTimeList":[[1731979800000,1731987000000],[1731992400000,1731999600000]],"highLimit":6.41,"lowLimit":5.25,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":349855339,"pbRate":1.7,"roa":"--","roe":"--","epsLYR":-0.3962,"marketValue":2243000000,"floatMarketCap":2205000000,"peRate":-9.672552,"changeRate":0.0995,"turnoverRate":0.0618,"status":0},"requestUrl":"/m/hq/s/000952/tweets","defaultTab":"tweets","newsList":[{"id":"2484995956","title":"异动快报:广济药业(000952)11月19日10点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2484995956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484995956?lang=zh_cn&edition=full","pubTime":"2024-11-19 10:15","pubTimestamp":1731982518,"startTime":"0","endTime":"0","summary":"证券之星11月19日盘中消息,10点14分广济药业触及涨停板。目前价格6.41,上涨9.95%。其所属行业化学制药目前上涨。11月18日的资金流向数据方面,主力资金净流出770.89万元,占总成交额8.8%,游资资金净流入418.31万元,占总成交额4.77%,散户资金净流入352.58万元,占总成交额4.02%。近5日资金流向一览见下表:广济药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900011198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000952","BK0191","BK0239"],"gpt_icon":0},{"id":"2483346086","title":"广济药业:子公司广化制药拟增资扩股引入投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2483346086","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483346086?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:54","pubTimestamp":1731660876,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","BK1574","01477","BK0191","BK1191","000952"],"gpt_icon":0},{"id":"2483346704","title":"广济药业最新公告:全资子公司广化制药拟增资扩股引入战略投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2483346704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483346704?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:53","pubTimestamp":1731660839,"startTime":"0","endTime":"0","summary":"广济药业公告,全资子公司广化制药拟在上海联合产权交易所预挂牌,通过增资扩股方式引入战略投资者。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500026794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","01477","BK1574","000952","BK0191","BK0239"],"gpt_icon":0},{"id":"2483346584","title":"广济药业(000952.SZ)子公司广化制药拟通过公开挂牌引入战略投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2483346584","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483346584?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:43","pubTimestamp":1731660221,"startTime":"0","endTime":"0","summary":"智通财经APP讯,广济药业(000952.SZ)发布公告,公司全资子公司湖北广化制药有限公司(以下简称“广化制药”)拟在上海联合产权交易所预挂牌,通过增资扩股方式引入战略投资者。公告称,公司为降低投资风险,顺利推进广化制药化学合成原料药基地项目建设,确保该项目可持续发展,通过上海联合产权交易所公开挂牌引入战略投资者,符合公司整体战略发展需要。本次增资扩股完成后,广化制药将不再纳入公司合并报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","000952","BK1574","01477","BK0191","BK1191"],"gpt_icon":0},{"id":"2483639789","title":"【企业动态】广济药业新增1件法院诉讼,案由为证券虚假陈述责任纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2483639789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483639789?lang=zh_cn&edition=full","pubTime":"2024-11-15 12:58","pubTimestamp":1731646698,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,11月13日广济药业(000952)新增1件法院诉讼如下:案号:(2024)鄂01民初594号法院:湖北省武汉市中级人民法院案由:证券虚假陈述责任纠纷原告:招某某被告:湖北广济药业股份有限公司案件类型:民事立案日期:2024年11月13日数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500017556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","BK0191","BK0239","000952"],"gpt_icon":0},{"id":"2483843191","title":"广济药业(000952)11月14日主力资金净买入616.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483843191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483843191?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:21","pubTimestamp":1731568886,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月14日收盘,广济药业报收于6.35元,上涨5.31%,换手率8.49%,成交量29.19万手,成交额1.84亿元。11月14日的资金流向数据方面,主力资金净流入616.26万元,占总成交额3.36%,游资资金净流入1220.63万元,占总成交额6.65%,散户资金净流出1836.88万元,占总成交额10.0%。广济药业主营业务:主要从事维生素B2、B6原料系列产品以及医药制剂产品的研发、生产和销售等业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400019668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000952","BK0191","BK0239"],"gpt_icon":0},{"id":"2481510474","title":"广济药业(000952)被立案,股民索赔分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2481510474","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481510474?lang=zh_cn&edition=full","pubTime":"2024-11-05 13:42","pubTimestamp":1730785320,"startTime":"0","endTime":"0","summary":" 2024 年10月25日,广济药业(维权)发布《关于收到中国证券监督管理委员会《立案告知书》的公告》,因公司涉嫌信息披露违法违规,根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规,中国证监会决定对公司立案。部分股民或许存在索赔机会。徐劲律师擅长在上市公司虚假陈述案件中为股民维权索赔,执业十余年来,曾代理投资者起诉多家上市公司成功索赔。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-05/doc-incuyvnx9024729.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-05/doc-incuyvnx9024729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0191","BK0239","000952"],"gpt_icon":0},{"id":"2480341440","title":"广济药业前期会计差错被行政监管,后又因违规信披被立案!","url":"https://stock-news.laohu8.com/highlight/detail?id=2480341440","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480341440?lang=zh_cn&edition=full","pubTime":"2024-11-04 11:28","pubTimestamp":1730690880,"startTime":"0","endTime":"0","summary":" 按照申万行业分类,广济药业(维权)属于医药生物-化学制药-原料药。 广济药业于1999年在深交所上市,是一家历经54年的国有高新技术企业,是湖北省唯一的省属医药上市企业,长江产业投资集团为公司控股股东。 2024年10月25日,公司发布了其收到的中国证券监督管理委员会下发的《立案告知书》,因涉嫌信息披露违法违规被立案调查。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-04/doc-incuwfyi5629110.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-04/doc-incuwfyi5629110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","000952","BK0191"],"gpt_icon":0},{"id":"2479887740","title":"广济药业(000952)被证监会立案,股民可索赔","url":"https://stock-news.laohu8.com/highlight/detail?id=2479887740","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479887740?lang=zh_cn&edition=full","pubTime":"2024-10-31 13:39","pubTimestamp":1730353140,"startTime":"0","endTime":"0","summary":" 2024年10月26日,公告广济药业(维权)被证监会立案的原因是涉嫌信息披露违法违规。去年11月,广济药业曾因信披违规被湖北证监局警示。这导致公司前期披露的上述财报中营业收入、营业成本等财务信息记载不准确,违反了《中华人民共和国证券法》相关规定。此次被证监会立案,有待证监会的进一步调查。 辽宁宏都律师事务所王奕尧律师提醒,广济药业索赔条件:上市后到2024-10-25之间买入股票,且在2024-10-26收盘时卖出或仍持有。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-31/doc-incummvx7102069.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-31/doc-incummvx7102069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0191","BK0239","000952"],"gpt_icon":0},{"id":"2479202292","title":"广济药业(000952)9月30日股东户数3.05万户,较上期减少1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479202292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479202292?lang=zh_cn&edition=full","pubTime":"2024-10-30 17:19","pubTimestamp":1730279987,"startTime":"0","endTime":"0","summary":"证券之星消息,近日广济药业披露,截至2024年9月30日公司股东户数为3.05万户,较6月30日减少614.0户,减幅为1.98%。在化学制药行业个股中,广济药业股东户数低于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.1万户。从股价来看,2024年6月30日至2024年9月30日,广济药业区间涨幅为17.64%,在此期间股东户数减少614.0户,减幅为1.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000032791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","000952"],"gpt_icon":0},{"id":"2479222374","title":"广济药业最新公告:拟公开挂牌转让湖北广济医药科技有限公司90%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2479222374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479222374?lang=zh_cn&edition=full","pubTime":"2024-10-30 16:49","pubTimestamp":1730278199,"startTime":"0","endTime":"0","summary":"广济药业公告,公司拟通过上海联合产权交易所挂牌的方式公开转让所持有的湖北广济医药科技有限公司90%股权,挂牌价不低于备案资产评估价对应股权价值4478.56万元。本次股权转让完成后,公司将不再持有医药科技公司股份,医药科技公司将不再纳入公司合并报表范围。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000029630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000952","BK0239","BK1515","09939","BK1574","159938","BK1161"],"gpt_icon":0},{"id":"2479722463","title":"广济药业:拟公开挂牌转让湖北广济医药科技有限公司90%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2479722463","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479722463?lang=zh_cn&edition=full","pubTime":"2024-10-30 16:42","pubTimestamp":1730277750,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0191","09939","159938","BK1161","BK0239","BK1515","000952","BK1574"],"gpt_icon":0},{"id":"2479924992","title":"广济药业(000952)遭证监会立案调查,将面临投资者索赔","url":"https://stock-news.laohu8.com/highlight/detail?id=2479924992","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479924992?lang=zh_cn&edition=full","pubTime":"2024-10-30 14:07","pubTimestamp":1730268420,"startTime":"0","endTime":"0","summary":" 2024年10月25日晚间,湖北广济药业(维权)股份有限公司广济药业发布公告称,公司于近日收到中国证监会下发的《立案告知书》。因涉嫌信息披露违法违规,根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规,中国证监会决定对公司立案。 广济药业本次被立案调查的原因尚不清楚。 信本股民索赔团队提醒,广济药业遭证监会立案,因此受损的投资者,可通过“信本股民索赔”自愿发起索赔登记。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-30/doc-incuihww1110416.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-30/doc-incuihww1110416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0191","BK0239","000952"],"gpt_icon":0},{"id":"2479419199","title":"广济药业涉嫌信披违规被立案,投资索赔预登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2479419199","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479419199?lang=zh_cn&edition=full","pubTime":"2024-10-29 11:21","pubTimestamp":1730172060,"startTime":"0","endTime":"0","summary":" 2024年10月26日,湖北广济药业(维权)股份有限公司于近日收到中国证券监督管理委员会下发的《立案告知书》。因涉嫌信息披露违法违规,根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规,中国证监会决定对公司立案。 罗建欣律师代理的部分投资者诉广济药业证券虚假陈述案目前正在有序推进,符合条件的投资者尽快加入索赔。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-29/doc-incuetkc8876438.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-29/doc-incuetkc8876438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000952","BK0191","BK0239"],"gpt_icon":0},{"id":"2479259413","title":"广济药业(000952)被证监会立案投资者可索赔,鹏欣资源(600490)索赔案持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2479259413","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479259413?lang=zh_cn&edition=full","pubTime":"2024-10-29 10:51","pubTimestamp":1730170260,"startTime":"0","endTime":"0","summary":" 2024年10月25日晚,广济药业(维权)公告收到证监会下发的《立案告知书》,因公司涉嫌信息披露违法违规,根据《证券法》《行政处罚法》等法律法规,证监会决定对公司立案。 上海久诚律师事务所主任许峰律师认为,综合此次立案调查公告以及广济药业此前发布的相关公告,暂定在2022年3月25日到2023年4月20日之间买入广济药业股票,并在2023年4月20日后卖出或继续持有股票的投资者,目前已可准备发起索赔。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-29/doc-incuetki4738704.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-29/doc-incuetki4738704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0182","BK0191","600490","000952","BK0188","BK0233","BK0127","BK0077","BK0239"],"gpt_icon":0},{"id":"2478122309","title":"广济药业(000952)10月28日主力资金净卖出709.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478122309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478122309?lang=zh_cn&edition=full","pubTime":"2024-10-28 15:23","pubTimestamp":1730100227,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月28日收盘,广济药业报收于5.95元,下跌2.3%,换手率7.48%,成交量25.74万手,成交额1.51亿元。10月28日的资金流向数据方面,主力资金净流出709.53万元,占总成交额4.69%,游资资金净流出343.88万元,占总成交额2.28%,散户资金净流入1053.41万元,占总成交额6.97%。广济药业主营业务:主要从事维生素B2、B6原料系列产品以及医药制剂产品的研发、生产和销售等业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800013656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000952","BK0239"],"gpt_icon":0},{"id":"2478499771","title":"华闻集团、广济药业、宁波方正遭证监会立案 投资者或可索赔","url":"https://stock-news.laohu8.com/highlight/detail?id=2478499771","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478499771?lang=zh_cn&edition=full","pubTime":"2024-10-28 11:35","pubTimestamp":1730086500,"startTime":"0","endTime":"0","summary":" 2024年10月25日晚间,华闻集团(维权)、广济药业(维权)、宁波方正(维权)三家上市公司均发布了关于收到中国证券监督管理委员会《立案告知书》的公告。目前尚不清楚华闻集团、广济药业此次遭证监会立案是否与此前的行政监管或警示函揭露的违规相关。 江苏振泽律师事务所合伙人张云律师表示,华闻集团、广济药业、宁波方正遭证监会立案,投资者或可索赔。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-28/doc-incuaqmf8876766.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-28/doc-incuaqmf8876766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0174","BK0108","BK0098","BK0086","BK0004","300998","000793","000952","BK0028","BK0188","BK0191","BK0239","BK0251","BK0268"],"gpt_icon":0},{"id":"2478714331","title":"广济药业、华闻集团股票索赔:涉嫌信披违规被立案,投资者可做索赔准备","url":"https://stock-news.laohu8.com/highlight/detail?id=2478714331","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478714331?lang=zh_cn&edition=full","pubTime":"2024-10-28 10:33","pubTimestamp":1730082780,"startTime":"0","endTime":"0","summary":" 近日,代理过多件重大影响案件的江苏博爱星律师事务所章祥兵律师特别提示,广济药业(维权)、华闻集团(维权)涉嫌信披违规被立案,投资者可做索赔准备。 2024年10月26日,广济药业、华闻集团分别发布公告称:“公司于近日收到中国证监会《立案告知书》。因涉嫌信息披露违法违规,根据相关法律法规,中国证监会决定对公司立案”。 目前,章祥兵律师正在开展广济药业、华闻集团受损投资者索赔预登记工作。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-28/doc-incuakci8982670.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-28/doc-incuakci8982670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0098","BK0012","BK0086","BK0028","BK0108","BK0188","BK0239","000793","000952","BK0174","BK0004","BK0268","BK0191"],"gpt_icon":0},{"id":"2478411701","title":"广济药业(000952)被立案,股民索赔可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2478411701","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478411701?lang=zh_cn&edition=full","pubTime":"2024-10-28 10:06","pubTimestamp":1730081160,"startTime":"0","endTime":"0","summary":" 2024年10月26日,湖北广济药业(维权)股份有限公司发布《关于收到中国证券监督管理委员会立案告知书的公告》,称因公司涉嫌信息披露违法违规等行为,根据《中华人民共和国证券法》的有关规定,中国证券监督管理委员会决定对公司立案调查。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-28/doc-incuakcf9795775.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-10-28/doc-incuakcf9795775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","000952","BK0191"],"gpt_icon":0},{"id":"2478186273","title":"本周累计10家上市公司公告公司或相关方被立案 公告次日诺泰生物盘中逼近20CM跌停","url":"https://stock-news.laohu8.com/highlight/detail?id=2478186273","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478186273?lang=zh_cn&edition=full","pubTime":"2024-10-27 10:09","pubTimestamp":1729994986,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0057","BK0070","BK0174","300998","BK0086","BK0108","BK0191","BK0189","000793","BK0026","BK0098","BK0177","BK0046","BK0239","000518","BK0109","BK0145","BK0037","BK0077","159982","600079","600360","BK0125","BK0028","BK0012","BK0004","000952","603880","688076","BK0251","BK0168","BK0185","300527","BK0268","BK0214","BK0096","399300","000670","BK0188","BK0198"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1999-11-12","address":"湖北省黄冈市武穴市大金镇梅武路100号","stockEarnings":[{"period":"1week","weight":-0.0348},{"period":"1month","weight":0.0523},{"period":"3month","weight":0.1637},{"period":"6month","weight":-0.0536},{"period":"1year","weight":-0.2838},{"period":"ytd","weight":-0.2703}],"companyName":"湖北广济药业股份有限公司","boardCode":"AI0027","perCapita":"11293股","boardName":"医药制造业","registeredCapital":"34985万元","compareEarnings":[{"period":"1week","weight":-0.0421},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.1595},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.0882},{"period":"ytd","weight":0.1173}],"survey":" 湖北广济药业股份有限公司主要从事维生素 B2、B6原料系列产品以及医药制剂产品的研发、生产和销售等业务。公司主要产品分为原料系列产品、制剂系列产品,其中:原料系列产品为医药级、食品级、98%饲料级、80%饲料级核黄素及核黄素磷酸钠;制剂系列产品为口服固体制剂和大输液。公司是国内较早从事维生素生产的企业之一,经过50多年的研发、生产与经营,现已成为国内生产规模领先、市场地位突出的生产企业,具有明显的规模优势。","serverTime":1731999299882,"listedPrice":5.03,"stockholders":"30459人(较上一季度减少1.98%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广济药业(000952)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广济药业(000952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广济药业,000952,广济药业股票,广济药业股票老虎,广济药业股票老虎国际,广济药业行情,广济药业股票行情,广济药业股价,广济药业股市,广济药业股票价格,广济药业股票交易,广济药业股票购买,广济药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广济药业(000952)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广济药业(000952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}